Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Deerfield Management Company, L.P.
Form 13F · Q2 2026

Deerfield Management Company, L.P.

CIK 1009258Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$9.6B
Reported book value
82
Positions
12
Quarters on record
Top 50
Positions

Deerfield Management Company, L.P. — holdings

Top 50 positions of 82, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1NUVALENT INC Nuvalent Inc17.2M+0.0%$2.1B22.2%
2RVMD Revolution Medicines Inc2.4M+4.1%$448M4.7%
3PRAX Praxis Precision Medicines I963,351+0.0%$323M3.4%
4VTRS Viatris Inc20.2M+0.0%$321M3.3%
5CNC Centene Corp Del4.9M−17.2%$315M3.3%
6UTHR United Therapeutics Corp Del457,000+0.0%$248M2.6%
7LEGN Legend Biotech Corp8.1M+5.9%$235M2.5%
8COGT Cogent Biosciences Inc5.0M−44.6%$194M2.0%
9GMAB Genmab A/S6.9M+178.8%$189M2.0%
10BROOKDALE SR LIVING INC Brookdale Sr Living Inc11.6M+0.0%$187M2.0%
11VERA Vera Therapeutics Inc3.9M+5.2%$168M1.8%
12IONS Ionis Pharmaceuticals Inc2.0M+0.0%$157M1.6%
13CELC Celcuity Inc1.5M−15.3%$152M1.6%
14BCRX Biocryst Pharmaceuticals Inc15.1M+0.4%$151M1.6%
15NAMS Newamsterdam Pharma Company4.3M+0.0%$145M1.5%
16ACHC Acadia Healthcare Company In4.5M+0.0%$133M1.4%
17TNGX Tango Therapeutics Inc4.2M+1.1%$131M1.4%
18AHCO Adapthealth Corp11.5M+0.0%$120M1.2%
19PHVS Pharvaris N V3.4M+8.0%$117M1.2%
20ARWR Arrowhead Pharmaceuticals In1.4M−11.7%$113M1.2%
21DNTH Dianthus Therapeutics Inc1.1M+10.3%$110M1.1%
22LRMR Larimar Therapeutics Inc35.6M+0.0%$109M1.1%
23MLYS Mineralys Therapeutics Inc4.0M—$107M1.1%
24IDYA Ideaya Biosciences Inc2.7M+77.4%$101M1.1%
25XENE Xenon Pharmaceuticals Inc1.6M+0.0%$98M1.0%
26SVRA Savara Inc13.6M+0.0%$84M0.9%
27LNTH Lantheus Hldgs Inc752,999−9.1%$84M0.9%
28SNDX Syndax Pharmaceuticals Inc3.8M+0.0%$83M0.9%
29BMRN Biomarin Pharmaceutical Inc1.3M+56.5%$76M0.8%
30PFE Pfizer Inc3.0M+0.0%$73M0.8%
31INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc1.6M−46.8%$68M0.7%
32BIO RAD LABS INC Bio Rad Labs Inc226,070+0.0%$66M0.7%
33SPRY Ars Pharmaceuticals Inc7.5M+0.0%$60M0.6%
34STOK Stoke Therapeutics Inc1.8M+0.0%$60M0.6%
35GPCR Structure Therapeutics Inc1.1M+41.4%$58M0.6%
36NVST Envista Holdings Corporation2.2M+0.0%$58M0.6%
37INSPIRE MED SYS INC Inspire Med Sys Inc1.3M−52.0%$58M0.6%
38CDNA Caredx Inc2.0M−8.8%$57M0.6%
39BSX Boston Scientific Corp1.3M—$56M0.6%
40BLTE Belite Bio Inc357,199+17.5%$55M0.6%
41PBLS Parabilis Medicines Inc1.9M—$51M0.5%
42CERT Certara Inc7.5M−3.8%$49M0.5%
43IRON Disc Medicine Inc657,000+0.0%$48M0.5%
44BBOT Bridgebio Oncology Therapeut4.9M+0.0%$37M0.4%
45TYRA Tyra Biosciences Inc1.0M+85.2%$32M0.3%
46MNPR Monopar Therapeutics Inc323,745+0.0%$30M0.3%
47SION Sionna Therapeutics Inc680,916−29.8%$30M0.3%
48AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc731,000—$24M0.3%
49FHTX Foghorn Therapeutics Inc4.4M+0.0%$21M0.2%
50BBNX Beta Bionics Inc1.3M+0.0%$21M0.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.